| Daniel D Denison, MD | |
|
2111 14th St, Meridian, MS 39301-4041 | |
| (601) 693-3834 | |
| (601) 484-3225 |
| Full Name | Daniel D Denison |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 19 Years |
| Location | 2111 14th St, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871637264 | NPI | - | NPPES |
| 07602854 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 21239 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anderson Regional Medical Ctr | Meridian, MS | Hospital |
| Mississippi Methodist Rehab Ctr | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anderson Regional Medical Center | 4284548025 | 33 |
News Archive
Researchers have developed a new type of food that improves gut bacteria in malnourished children and kick-starts growth.
Hewlett-Packard on Monday announced it will provide "smartphones and cloud computing technology to nonprofit group Positive Innovation for the Next Generation (PING)" to help improve health monitoring and malaria detection in Botswana, Venture Beat reports.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
› Verified 5 days ago
| Entity Name | Anderson Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043764699 PECOS PAC ID: 4284548025 Enrollment ID: O20170405001138 |
News Archive
Researchers have developed a new type of food that improves gut bacteria in malnourished children and kick-starts growth.
Hewlett-Packard on Monday announced it will provide "smartphones and cloud computing technology to nonprofit group Positive Innovation for the Next Generation (PING)" to help improve health monitoring and malaria detection in Botswana, Venture Beat reports.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel D Denison, MD 2111 14th St, Meridian, MS 39301-4041 Ph: (601) 693-3834 | Daniel D Denison, MD 2111 14th St, Meridian, MS 39301-4041 Ph: (601) 693-3834 |
News Archive
Researchers have developed a new type of food that improves gut bacteria in malnourished children and kick-starts growth.
Hewlett-Packard on Monday announced it will provide "smartphones and cloud computing technology to nonprofit group Positive Innovation for the Next Generation (PING)" to help improve health monitoring and malaria detection in Botswana, Venture Beat reports.
A newer, less invasive method of heart valve replacement shows promise and may be appropriate for patients who cannot tolerate traditional open heart surgery, but research is needed to understand its potential risks and benefits, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
› Verified 5 days ago
Stephen W Tartt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834 Fax: 601-484-3225 | |
Sarah Tabb, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2124 14th St, Meridian, MS 39301 Phone: 601-553-6000 | |
Dr. Leslie B. Gray, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-484-6700 | |
Dr. David A. Makey, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9233 | |
William A Billups Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834 Fax: 601-484-3225 | |
Hans Hunt Tulip, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834 Fax: 601-693-6275 | |
Johnathan Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, 3rd Floor, Meridian, MS 39301 Phone: 601-703-9970 |